{
    "Trade/Device Name(s)": [
        "BD Kiestra Methicillin-resistant Staphylococcus aureus (MRSA) Application",
        "BD Kiestra MRSA App"
    ],
    "Submitter Information": "BD Kiestra B.V.",
    "510(k) Number": "K213280",
    "Predicate Device Reference 510(k) Number(s)": [
        "K200839"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "QQY"
    ],
    "Summary Letter Date": "May 4, 2023",
    "Summary Letter Received Date": "October 1, 2021",
    "Submission Date": "September 30, 2021",
    "Regulation Number(s)": [
        "21 CFR 866.2190"
    ],
    "Regulation Name(s)": [
        "Automated Image Assessment System For Microbial Colonies On Solid Culture Media"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Methicillin-resistant Staphylococcus aureus (MRSA)"
    ],
    "Specimen Type(s)": [
        "Anterior nares sample"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BD Kiestra Laboratory Automation Solution",
        "BD Kiestra InoqulA",
        "BD Kiestra InoqulA+",
        "BD Kiestra ReadA",
        "BD Kiestra ReadA Compact",
        "BD Synapsys informatics solution"
    ],
    "Method(s)/Technology(ies)": [
        "Digital image analysis",
        "Image algorithm",
        "Colorimetric detection"
    ],
    "Methodologies": [
        "Automated imaging",
        "Colony growth assessment",
        "Colorimetric screening"
    ],
    "Submission Type(s)": [
        "Software",
        "Analysis module",
        "Accessory"
    ],
    "Document Summary": "FDA 510(k) summary for BD Kiestra MRSA App, an in vitro diagnostic software for automated image analysis to aid in screening for nasal MRSA colonization using the BD Kiestra Laboratory Automation Solution.",
    "Indications for Use Summary": "In-vitro diagnostic software applied to digital images of BD BBL CHROMagar MRSA II plates inoculated with anterior nares samples to qualitatively assess colony growth and detect MRSA nasal colonization, aiding prevention and control of MRSA infection; not for guiding, diagnosing, or monitoring MRSA infections or susceptibility testing.",
    "fda_folder": "Microbiology"
}